These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32090363)

  • 1. A systematic review and combined meta-analysis of concentration of oral amisulpride.
    Li L; Li L; Shang DW; Wen YG; Ning YP
    Br J Clin Pharmacol; 2020 Apr; 86(4):668-678. PubMed ID: 32090363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amisulpride doses and plasma levels in different age groups of patients with schizophrenia or schizoaffective disorder.
    Müller MJ; Eich FX; Regenbogen B; Sachse J; Härtter S; Hiemke C
    J Psychopharmacol; 2009 May; 23(3):278-86. PubMed ID: 18562411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic drug monitoring for optimizing amisulpride therapy in patients with schizophrenia.
    Müller MJ; Regenbogen B; Härtter S; Eich FX; Hiemke C
    J Psychiatr Res; 2007 Oct; 41(8):673-9. PubMed ID: 16324716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on the relationship among dose, concentration and clinical response in Chinese schizophrenic patients treated with Amisulpride.
    Sun F; Yu F; Gao Z; Ren Z; Jin W
    Asian J Psychiatr; 2021 Aug; 62():102694. PubMed ID: 34052710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma amisulpride levels in schizophrenia or schizoaffective disorder.
    Bergemann N; Kopitz J; Kress KR; Frick A
    Eur Neuropsychopharmacol; 2004 May; 14(3):245-50. PubMed ID: 15056484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling and Simulation for Individualized Therapy of Amisulpride in Chinese Patients with Schizophrenia: Focus on Interindividual Variability, Therapeutic Reference Range and the Laboratory Alert Level.
    Huang S; Li L; Wang Z; Xiao T; Li X; Liu S; Zhang M; Lu H; Wen Y; Shang D
    Drug Des Devel Ther; 2021; 15():3903-3913. PubMed ID: 34548782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age, Sex, and Comedication Effects on the Steady-State Plasma Concentrations of Amisulpride in Chinese Patients with Schizophrenia.
    Yang S; Wang H; Zheng GF; Wang Y
    Ther Drug Monit; 2023 Oct; 45(5):676-682. PubMed ID: 36863030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clozapine combined with different antipsychotic drugs for treatment-resistant schizophrenia.
    Barber S; Olotu U; Corsi M; Cipriani A
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD006324. PubMed ID: 28333365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender aspects in the clinical treatment of schizophrenic inpatients with amisulpride: a therapeutic drug monitoring study.
    Müller MJ; Regenbogen B; Sachse J; Eich FX; Härtter S; Hiemke C
    Pharmacopsychiatry; 2006 Mar; 39(2):41-6. PubMed ID: 16555163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amisulpride - dose, plasma concentration, occupancy and response: implications for therapeutic drug monitoring.
    Sparshatt A; Taylor D; Patel MX; Kapur S
    Acta Psychiatr Scand; 2009 Dec; 120(6):416-28. PubMed ID: 19573049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amisulpride steady-state plasma concentration and adverse reactions in patients with schizophrenia: a study based on therapeutic drug monitoring data.
    Qu K; Zhou Q; Tian L; Shen Y; Zhou Z
    Int Clin Psychopharmacol; 2022 Nov; 37(6):255-262. PubMed ID: 35779068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amisulpride for schizophrenia.
    Mota NE; Lima MS; Soares BG
    Cochrane Database Syst Rev; 2002; 2002(2):CD001357. PubMed ID: 12076408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluphenazine (oral) versus atypical antipsychotics for schizophrenia.
    Sampford JR; Sampson S; Li BG; Zhao S; Xia J; Furtado VA
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010832. PubMed ID: 27370402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimation of rac-amisulpride transfer into milk and of infant dose via milk during its use in a lactating woman with bipolar disorder and schizophrenia.
    Teoh S; Ilett KF; Hackett LP; Kohan R
    Breastfeed Med; 2011 Apr; 6(2):85-8. PubMed ID: 20925494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Olanzapine versus other atypical antipsychotics for schizophrenia.
    Komossa K; Rummel-Kluge C; Hunger H; Schmid F; Schwarz S; Duggan L; Kissling W; Leucht S
    Cochrane Database Syst Rev; 2010 Mar; (3):CD006654. PubMed ID: 20238348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of effect of amisulpride on the pharmacokinetics and safety of lithium.
    Canal M; Legangneux E; van Lier JJ; van Vliet AA; Coulouvrat C
    Int J Neuropsychopharmacol; 2003 Jun; 6(2):103-9. PubMed ID: 12890302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D2 receptor occupancy during high- and low-dose therapy with the atypical antipsychotic amisulpride: a 123I-iodobenzamide SPECT study.
    la Fougère C; Meisenzahl E; Schmitt G; Stauss J; Frodl T; Tatsch K; Hahn K; Möller HJ; Dresel S
    J Nucl Med; 2005 Jun; 46(6):1028-33. PubMed ID: 15937316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pilot study of the safety and efficacy of amisulpride and risperidone in elderly psychotic patients.
    Riedel M; Eich FX; Möller HJ
    Eur Psychiatry; 2009 Apr; 24(3):149-53. PubMed ID: 19070995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolactinemia is uncoupled from central D2/D3 dopamine receptor occupancy in amisulpride treated patients.
    Bressan RA; Erlandsson K; Spencer EP; Ell PJ; Pilowsky LS
    Psychopharmacology (Berl); 2004 Sep; 175(3):367-73. PubMed ID: 14997280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative efficacy and safety between amisulpride and olanzapine in schizophrenia treatment and a cost analysis in China: a systematic review, meta-analysis, and cost-minimization analysis.
    Men P; Yi Z; Li C; Qu S; Xiong T; Yu X; Zhai S
    BMC Psychiatry; 2018 Sep; 18(1):286. PubMed ID: 30185173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.